The US–China techbio summit for early and growth-stage companies. Accelerating medicine across borders. Shanghai · Oct 26–27, 2026

Joined August 2026
🏮Announcing the Lantern Summit in Shanghai🏮 In 2025, more new medicines launched first in China than anywhere else on Earth. That has never happened before. Drug development has two simultaneous accelerators: •⁠ ⁠AI is collapsing design (weeks instead of years). •⁠ ⁠China is collapsing development (physical iteration speed). Here is why that matters, and what Western biotech is missing: 🧵
8
22
3
53
60,016
Dr. Guoxin Zhu joins us at The Lantern Summit. SVP and Global Head of Research at Hengrui. Ex-VP of Molecule Discovery at Eli Lilly, where he oversaw 100+ small molecule clinical candidates. Shanghai · 26–27 Oct 2026 thelanternsummit.com 🏮
2
27
Dr. Yue Wang joins us at The Lantern Summit. VP at AstraZeneca China R&D and Head of Digital Health. Her teams have supported 15 innovative medicine approvals and 35 new indications in China. Shanghai · 26–27 Oct 2026 thelanternsummit.com 🏮
1
22
Katherine Jones joins us at The Lantern Summit. First operations hire at @merge, the ultrasound BCI company co-founded by Sam Altman. Led neurotech investing at Hummingbird. Now at @JoinEdgeCity. Shanghai · 26–27 Oct 2026 thelanternsummit.com
2
4
206
Jeff Wang joins us at The Lantern Summit. Founder of Global Pharma Navigator, a network of 30,000+ manufacturers across Chinese biopharma. A decade in API manufacturing before he built it. Shanghai · 26–27 Oct 2026 thelanternsummit.com🏮
3
258
Phoenix Peng joins us at The Lantern Summit. Founder & CEO of Gestala, China's first ultrasound brain-computer interface company: RMB 570M raised since January. Co-founded NeuroXess before that. Shanghai · 26–27 Oct 2026 thelanternsummit.com
1
1
78
Dato’ William Woo joins us at The Lantern Summit. Chairman and CEO of ChemPartner, the drug discovery CRO and CDMO. Co-founder of Perfect China. Thirty years building healthcare businesses in China. Shanghai · 26–27 Oct 2026 thelanternsummit.com
1
64
Dr. Dan Zhang joins us at The Lantern Summit. Founder of Fountain Medical Development, now ClinChoice, and co-chairman of cell-therapy CDMO Hillgene. Fudan professor, ICH expert, PUMC medical doctorate. Shanghai · 26–27 Oct 2026 thelanternsummit.com 🏮
2
59
Roberta lipson joins us at The Lantern Summit. Founder of United Family Healthcare. Co-founded Chindex in 1981 and opened China’s first foreign-invested hospital in 1997. Chair emeritus of AmCham China. Shanghai · 26–27 Oct 2026 thelanternsummit.com 🏮
3
67
Ugur Sahin led the development of the first approved mRNA COVID-19 vaccine and helped establish mRNA as a new class of medicine. He keynotes The Lantern Summit: “From Science to Survival: a personal perspective on turning ideas into impact for patients.” Shanghai · 26–27 Oct 2026 thelanternsummit.com 🏮
3
7
312
LanternSummit retweeted
Bio is having its China moment. Just booked flights to join & add a bit of California Peptide Club flavor. DM me if you're coming or are interested!
🏮Announcing the Lantern Summit in Shanghai🏮 In 2025, more new medicines launched first in China than anywhere else on Earth. That has never happened before. Drug development has two simultaneous accelerators: •⁠ ⁠AI is collapsing design (weeks instead of years). •⁠ ⁠China is collapsing development (physical iteration speed). Here is why that matters, and what Western biotech is missing: 🧵
1
7
362
Michael Yin joins us at The Lantern Summit. Chairman of Suzhou BioBAY, the park that helped make Suzhou Industrial Park China's top-ranked biopharma cluster. He also hosts our optional Day 3 visit. Shanghai · 26–27 Oct 2026 thelanternsummit.com 🏮
1
2
149
Wenliang Lei joins us at The Lantern Summit. PI at Jinan University's GHM Institute of CNS Regeneration. His lab builds primate models of Alzheimer's and tests AAV gene therapy in them. Shanghai · 26–27 Oct 2026 thelanternsummit.com🏮
3
92
Jeff He joins us at The Lantern Summit. Co-founder and CEO of TandemAI, pairing AI and physics-based models with wet labs in the US and China. Co-founded HiFiBiO and Harbour BioMed before that. Shanghai · 26–27 Oct 2026 thelanternsummit.com🏮
3
87
Alan Jiang joins us at The Lantern Summit. Chief Strategy Officer at @XtalPi (2228.HK), where AI, quantum physics and robotic labs meet drug R&D. Twenty years at Genzyme and Sanofi before that. Shanghai · 26–27 Oct 2026 thelanternsummit.com 🏮
1
4
143
Jielun Zhu joins us at The Lantern Summit. Co-founder, CFO & CBO of Excalipoint, whose $68.7M seed is among the largest ever for a Chinese biotech. Led I-Mab's Nasdaq IPO as CFO before that. Shanghai · 26–27 Oct 2026 thelanternsummit.com🏮
1
6
137
Kerry Blanchard joins us at The Lantern Summit. CEO of Perpetual Medicines and President of R&D at TandemAI. Four decades of drug hunting, the last 16 in China: Lilly China, Innovent, Everest Medicines. Shanghai · 26–27 Oct 2026 thelanternsummit.com🏮
2
62
Carol Magalhaes joins us at The Lantern Summit. Co-founder of Autonomy Bio, an age1-incubated company working on healthy lifespan. George Church's lab before that; left a Stanford PhD to build it. Shanghai · 26–27 Oct 2026 thelanternsummit.com 🏮
6
49
Vince Deng joins us at The Lantern Summit. CFO of OnTargetBio and Venture Partner at Med-Fine Capital, a seed investor in Excalipoint. Glycoscientist by training; published in Cell and PNAS. Shanghai · 26–27 Oct 2026 thelanternsummit.com 🏮
3
79
Dan Wee joins us at The Lantern Summit. Chief eXecution Officer at @enveda since before the seed round. Enveda closed a $311M Series E in September at a $2B valuation, three medicines in the clinic. Shanghai · 26–27 Oct 2026 thelanternsummit.com 🏮
1
4
114